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ABSTRACT
Medication errors involving hospitalized patients have been an evolving challenge
for decades. Moreover, errors related to intravenous (IV) medication administration
continue to rise in hospitals despite implemented policies governing the use of
Guardrails™ for safe IV medication infusion via smart pump technology. An
organizational investigation was performed to identify barriers to the use of Guardrails™
among nursing staff. From 2015 through 2017, multiple interventions that aimed to
identify barriers and increase nurses’ use of the safety features on IV smart pumps were
implemented in the hopes of reaching a compliance goal of 90-100%. This quality
improvement project assesses Guardrails™ compliance with smart pumps since its initial
integration in 2010 and through 2017. A systematic organizational assessment was
conducted at a Magnet®-recognized facility in South Carolina to identify the factors that
influence the use of Guardrails™ by nurses, implement changes based on the assessment,
measure outcomes, and make recommendations for future change to foster continued
progress towards the 90-100% benchmark. Participants included all nurses who utilized
the smart pumps with Guardrails™ (N=2,500). The results provided insights into the
factors that either succeeded or not through collaboration with numerous stakeholders,
metrics on Guardrails™ utilization, self-reported IV medication errors per year, and a
pre- and post-project survey. The project offered valuable information that was used to
implement changes that eventually resulted in an increase in nurses' compliance with
Guardrails™ use, provided recommendations for sustaining compliance, and proposed
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updates to the facility's IV medication administration policy. The data results from the
Guardrails™ compliance report and IV medication error rate between 2015 and 2017
provided enough evidence to suggest that a structured continuous education plan is
essential to increase nurses’ awareness and adherence to policies and procedures
governing the use of Guardrails™ on IV smart pumps.
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CHAPTER I
INTRODUCTION
Medical errors account for 10% of deaths in the United States (U.S.) every year
and have now been rated as the third leading cause of death in the U.S. (Sternberg, 2016).
Medication errors are part of this horrible statistic. One approach to reducing intravenous
(IV) medication errors is the use of smart pump technology (Association for the
Advancement of Medical Instrumentation [AAMI] and the Healthcare Technology Safety
Institute, 2014). The purpose of this quality improvement project was to conduct a
systematic organizational assessment to identify factors that influence use of
Guardrails™ safety features by nurses, implement changes based on the assessment,
measure outcomes, and make recommendations for change. Chapter I provides a
description of the clinical problem, scope of the problem, clinical environment, analysis
of clinical problem, the evidence-based practice (EBP) question and the populationintervention-comparison-outcome-time (PICOT) definitions, and assumptions.
Description of the Clinical Problem
In the 1990s, smart IV pump technology began to be used in hospital-specific
areas (Vanderveen, 2014). IV smart pumps were designed to help prevent IV medication
errors (Gavriloff, 2012). However, human mistakes continued to occur, directly affecting
patient safety (Institute for Safe Medication Practice [ISMP], 2013). In 2008, the facility
decided to adopt the newly innovative IV smart pump technology in an effort to increase
IV medication safety and improve patient outcomes. In 2010, the facility noticed a
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significant increase in IV medication errors with 978 IV medication errors. The facility
contacted the makers of the Alaris® IV smart pumps (e.g. CareFusion®) and
implemented Guardrails™ safety features into the IV smart pump's drug libraries in April
of 2010. The Guardrails™ safety features were added to the IV smart pumps to prevent
IV medication errors. The hospital set a goal that nurses would use the smart pump and
Guardrails™ safety features 90-100% of the time. Despite implementing Guardrails™
safety features, metrics on IV medication errors and Guardrails™ utilization were below
benchmark, as compliance data revealed that nurses used Guardrails less than 75% of the
time. Also, there were approximately 1,000 cases of IV medication errors reported
between 2011 through 2016. Nurses were not using the Guardrails™ safety features on
IV smart pumps. The question is “why?”
Scope of Problem
A number of authors have identified the problem of use of Guardrails™ safety
features by nurses. Gavriloff (2012) found that nurses used medication safety software
properly 28% of the time. In addition, Gavriloff (2012) provided evidence that, with
effective education strategies, staff adherence rates went from 28% to 85% within a
week. However, education did not prevent errors unless the software was programed
properly and nurses used the features (Gavriloff, 2012). Sullivan and Palillo (2014)
identified that of 5780 intensive care units (ICUs) IV smart pump alarms, 7% were
referencing dose corrections. They concluded that nurses lacked understanding of IV
smart pump technology that may potentially be influenced by their perceptions, which led
to incorrect modification of the pump. Rosenkoetter, Bowcutt, Khasanshina, Chernecky,
and Wall (2008) came to the same conclusion. Perceptions played a large part in the
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implementation of new technology in hospitals. Harding (2012) called for better
understanding of how nurses use smart pumps and noted that a distinct culture of noncompliance existed in hospitals that required rigorous monitoring and education. Harding
(2012) concluded that the problem may be due to nurses’ lack of understanding of the
features on smart pumps, hospital policy and procedures related to smart pumps, or
failure to acknowledge the legal jeopardy when bypassing the IV smart pump drug
libraries. If patient harm occurs as a result of nurse’s non-compliance with smart pump
technology, the nurse could be at fault in court proceedings (Harding, 2012). In a study
conducted by Westbrook, Rob, Woods, and Parry (2011), findings revealed that of 101
serious IV administration errors, 95 errors resulted from the use of the wrong IV rate. The
authors identified that routine violations with the use of IV smart pumps stemmed from
behaviors learned in the workplace (Westbrook, Rob, Woods, & Parry, 2011).
Alaris® IV smart pumps for the administration of IV medications were initiated
in the facility in 2008. Two years later, the instances of IV medication errors remained
high prompting the facility to enhance the smart pumps by upgrading their Guardrails™
safety features in 2010 to increase patient safety. Guardrails™ is “a hospital-defined list
of drugs and concentrations appropriate for use in as many as 15 profiles”
(Alaris®Guardrails, 2016, p.1). The quality assurance data reported on all self-reported
IV medication errors and near misses at the facility remained at an all-time high from
2010 through 2015. In 2011, there were approximately 1500 documented cases of selfreported IV medication errors within the facility. Also, errors related to IV medication
administration cost the facility millions of dollars. For example, the facility paid $3.8
million to five families for injuries that resulted from medication errors (Monk, 2002).
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The AAMI (2014) postulated that planning ahead and creating an effective plan to
monitor compliance was highly recommended before integrating systems of infusion
pumps. Unfortunately, the facility did not establish an effective plan to monitor
compliance data before smart pumps and Guardrails™ were introduced. In January of
2015, a hospital-wide electronic survey was sent to all nurses who administered IV
medications to determine barriers to use of smart pumps with Guardrails™. In March of
the same year, the Alaris Guardrails™ Team (AGT) was formed and consisted of two
nurse managers, a pharmacist, a performance improvement facilitator, a critical care staff
nurse who joined the team in March of 2016, and two nursing patient facilitators who
recently joined the team in September of 2016. Their charge was to use the data from the
survey to identify barriers to the use of smart pumps and Guardrails™ drug libraries by
nurses and implement needed changes.
Clinical Environment
The project will took place at one of only three Magnet® recognized institutions
in South Carolina. The institution is a 700-bed academic hospital accounting for over one
million patient encounters per year. There were a total of 7,000 employees, which
included 750 physicians and 2,500 nurses. In addition, the institution experienced
approximately 36,114 inpatient encounters and 1,205,066 outpatients encounters every
year. The project included all 58 inpatient and outpatient units that utilized smart pumps
with Guardrails™ safety features. There were approximately 740 licensed beds among all
four hospitals managed by the facility.
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Analysis of Current Practices
After analyzing practices implemented when IV smart pumps were integrated at
the facility, metrics on adherence to Guardrails™ safety features revealed that nurses
utilized Guardrails™ less than 75% of the time, placing the facility in the 28th percentile
compared to 764 other institutions that utilized CareFusion® smart pumps technology
(Dykema, 2015). The data on use of IV smart pumps with Guardrails™ features
suggested that a more structured process of change was needed. This conclusion
prompted the institution to develop the AGT charged with implementing interventions to
increase use of Guardrails™ by nurses. The benchmark set was for nurses to use
Guardrails™ 90-100% of the time.
Purpose
The purpose of this quality improvement project was to conduct a systematic
organizational assessment to identify factors that influence use of Guardrails™ by nurses,
implement interventions based on the assessment, measure outcomes, and make
recommendations for future change in order to foster continued progress toward the
benchmark set by the facility of 90-100% of the time.
Theoretical Framework
The theoretical framework used to guide this quality improvement project was
adopted from Kurt Lewin’s Change Management Theory in Figure 1.1 (see Appendix A).
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Figure 1.1 Kurt Lewin's Change Management Model
Project Questions
Prospective questions included 1) as IV smart pump’s Guardrails™ compliance
rate increases, does self-reported IV medication errors decrease; 2) does the number of
self-reported IV medication errors decrease with implementation of each intervention, if
so, what factors significantly impacted increasing compliance rates, and why; 3)
according to data from the post hospital-wide survey, are there new barriers identified by
staff nurses, if so, what are these barriers; and 4) does the post nursing survey report an
increase in staff nurse’s knowledge and awareness regarding proper utilization and
adherence to IV smart pump’s Guardrails™ policies and procedures.
EBP Question and PICOT Definitions
The EBP and the PICOT definitions are based on the format developed by
Melnyk and Fineout-Overholt (2011). The EBP question is “For hospital based nurses
using smart pumps with Guardrails™ (P), what are the factors that influence the use of
smart pumps with Guardrails (I) after implementing interventions based on the 2015
systematic organizational assessment and hospital-wide survey (C) as measured by the
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2017 hospital-wide systematic organizational assessment and survey, percent of use of
Guardrails™ by nurses, and self-reported IV medication errors per month? The PICOT
definitions are given in Table 1.1. Other definitions are stated below.
IV smart pump technology: According to the U.S. Food and Drug Administration
([FDA], 2014), an IV smart pump is technology that is “equipped with safety features,
such as user-alerts that activate when there is a risk of an adverse drug interaction, or
when the user sets the pump’s parameters outside of specified safety limits” (para 6).
Guardrails™: The Guardrails™ features may also be defined as a “drug library use (that)
automates programming steps, including drug name, drug amount and diluent volume,
and activates hospital-based established best practice limits” (Alaris®Guardrails, 2016,
p.1). Factors: According to Harris (2017) a factor is considered “a circumstance [which]
contribute(s) to a result” (para 12). For the purpose of this project, the term factors
include things like interruptions and distractions which impacts or contributes to a result
(Hughes & Blegen, 2008).

Table 1.1 PICOT Definitions
P-Population

I-Intervention

C-Comparison

O-Outcome

Hospital based nurses
using smart pumps with
Guardrails™

Factors that
influence the use of
smart pumps with
Guardrails™ policy
and procedures

Implementing
interventions based
on the 2015
systematic
organizational
assessment and
hospital-wide survey

Hospital-wide
systematic
organizational
assessment and
survey, percent of
use of Guardrails™
by nurses, and selfreported IV
medication errors
per month
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TTime
2
Years

Assumptions
This quality improvement project requires active involvement of stakeholders,
nurses, pharmacy, and unit managers. The quality improvement project assumed that staff
nurses will actively participate in providing feedback to the survey. In addition, the
project assumed that nurses would possess commitment to proper use of the smart pumps
with Guardrails™ safety features.
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CHAPTER II
LITERATURE REVIEW
The AGT searched the literature to determine what others had identified as factors
influencing use of Guardrails™ safety features by nurses. In addition, the AGT searched
for interventions that had been implemented to increase use of Guardrails by nurses.
Chapter II contains a description of the search process to include search terms and
databases, synthesis of the literature, development of the interventions, barriers to
implementation, and summary.
Search Process
The literature search occurred from January 15th, 2016 through March 4, 2016.
CINAHL Complete, PubMed, Joanne Briggs Institute, Cochrane Library, and Google
databases were used in the search process. CINAHL Complete was the first database
searched.
CINAHL Complete
CINAHL Complete offered an abundance of articles while using the search terms
compliance, smart pumps, and guardrails. Each of the search terms was placed in separate
search boxes, independent of each other. The "text all" option was then chosen for each
search term. The search option was selected and 268 articles were retrieved; however,
only eight of the items were selected, as they all pertained to the EBP question. All other
items were then eliminated because either the title or the article did not relate to the EBP

9

question. The review continued with the CINAHL database and the search term quality
improvement was used along with the term guardrails. Once more, the "text all" option
was selected for both terms and 282 articles were recovered. Six of the articles were
selected because they matched the EBP question. All others were eliminated because they
were duplicates or did not pertain to the EBP question. During the search in the CINAHL
database, several terms were used to narrow the search. The search terms used were
usage, guardrails smart pumps, and assessment. A total of 519 articles were retrieved, but
none of the articles were used because they were either duplicates or the article did not
pertain to the EBP question. As the CINAHL search continued, the terms increase
compliance, guardrails, and smart pumps revealed only two duplicate articles that were
previously selected. Also, the terms continuous quality initiative, adherence, and smart
pumps revealed only one article that did not relate to the EBP question. The terms drug
library, adherence, and nurses revealed 308 articles. Eight were selected while the terms
IV medication errors and smart pumps together revealed 51 articles with six selected that
were in congruence with the EBP question. Finally, the terms IV medication errors, smart
pumps, and Guardrails revealed several articles that included seven duplicates and others
that failed to support the EBP question.
PubMed
The PubMed database revealed 103 articles using the search term of factors that
influence the use of guardrails. Only 2 articles were eliminated because they were not
relevant to the EBP question. The term increase guardrails utilization was then used as
the search option, and 0 articles were retrieved. When the term increase IV drug library
use was used, 50 articles were identified. Only 1 article matched the EBP question.
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Finally, the search term increase use of guardrails revealed 51 articles of which 2
pertained to the EBP question. All others were eliminated because they did not support
the project or the titles did not match the EBP question.
Joanna Briggs Institute
Joanna Briggs Institute was the third search engine used for the review. In
general, the Joanna Briggs database offered the least amount of information. The first
terms used in combination were IV medication errors and guardrails, which failed to
recover any articles. Using the combined terms of IV smart pumps and drug libraries,
with the publication type of evidence and summaries options selected in the search box, 3
articles were identified; 1 of which pertained to the EBP question while the others were
not used.
Cochrane Library
The Cochrane Library only offered two articles that pertained to the EBP
questions. Both articles were retrieved using the combined search terms of smart pumps
and drug libraries. The terms smart pump, guardrails, nurse compliance to guardrails, and
guardrail usage were also used and failed to identify any articles. After using all four
databases, each article that was chosen was thoroughly reviewed, and eight articles were
recovered from the reference section of randomly selected articles.
Google Search Engine
To conclude, the Google search engine was used to explore the FDA, the ISMP,
and the Alaris CareFusion® websites. Overall, the search process was extensive and
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identified high-quality information related to the project. The inclusion and exclusion
criteria is presented below offers a distinct criteria for the articles selected for the purpose
of this project.
Inclusion and Exclusion Criteria
All articles were carefully reviewed for the second selection process. Descriptions
and quality ratings were assigned based on the evidence evaluation tool adopted from the
John Hopkins Nursing evidence-based practice model and guidelines (Dearholt and
Dang, 2012). Throughout the search process, all articles that were related to the EBP
question were used based on several inclusion criteria. First, articles were selected based
on the number of times they had been cited and used by others in the literature. Second,
all articles were chosen if they appropriately supported the EBP question. Third, articles
that were greater than five years old were used only if they supported the EBP question
and received high evidence ratings. Last, several articles suggested evaluating and
reviewing articles that applied to observational continuous quality initiative (CQI) or
time-motion studies. Exploration of the area of human factors was also mentioned in
various articles as an aspect to consider when smart pumps were integrated.
Therefore, several articles on time-motion studies as they related to smart pump
utilization and increasing guardrails usage were reviewed at random times throughout the
search process. These articles were not included in the literature review and synthesis
because they did not offer significant information to answer the EBP question. Table 2.1
summarizes the search process to include databases, search terms, number of articles
retrieved, and number of articles used.
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Table 2.1 Search Process
CINAHL
Search Terms
Compliance, smart pumps, guardrails
Quality Improvement, guardrails
Best practice, infusion safety, guardrails
Usage, guardrails, smart pumps
Assessment, guardrails, smart pumps
Increase compliance, guardrails, smart pumps
Continuous quality initiative, adherence, smart pumps
Drug library, adherence, nurses
IV medication errors, smart pumps
IV medication errors, smart pumps, guardrails

Number of Articles Retrieved
268
282
267
253
266
2
1
308
51
9

Number of Articles Used
8
6
3
0
0
2: duplicated articles
0
8
6
7: 7 repeated articles, others did not pertain to PICOT in
question.

Search Terms
Factors that influence the use of guardrails
Increase guardrails utilization
Increase IV drug library use
Increase use of guardrails
Joanne Briggs

Number of Articles Retrieved
2
0
50
51

Number of Articles Used
0
0
1
2

Search Terms
IV medication errors guardrails
IV smart pumps
Smart pump; (with publication type of evidence and summaries
Highlighted in search box).
Cochrane Library

Number of Articles Retrieved
0
0

Number of Articles Used
0
0

3

1

PubMed
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Search Terms
Smart pump drug libraries
Smart pump guardrails
Nurse compliance to guardrails
Guardrails usage

Number of Articles Retrieved
2
0
0
0

Number of Articles Used
2
0
0
0

Synthesis of the Literature
Content from 27 articles was used in the process of developing the evidencebased interventions to increase the use of Guardrails™ safety features by nurses. The
literature was organized according to the approaches or interventions recommended. The
categories are as follows: smart pump champions and continued quality programs (SPCs
& CQPs), education (E), organizational culture and medication errors (OC & ME), and
smart pump evaluation and surveillance methods (SPESM). The SPCs and CQPs
category included 7 articles while 3 were in the E category, 7 in the OC and ME
category, and 10 were in the SPESM category. Table 2.2 presents the evidence table by
category.
Smart Pump Champions & Continuous Quality Programs
Patient safety is a priority in hospitals (ISMP, 2013). Orto, Hendrix, Griffith, and
Shaikewitz (2015) performed a quality improvement project that measured the impact of
a pump champion program aimed to improve compliance with IV smart pump drug
libraries over the course of six months. The overall goal of the project was aimed at
impacting patient safety by decreasing IV medication errors (Orto et al., 2015). Results
revealed that a smart pump champion program was useful, as the drug libraries'
compliance rate increased from 83.5% pre-champion implementation to 92% postchampion implementation (Orto et al., 2015). The AAMI (2014) also suggested that
facilities adopt and establish a champion when medical devices were implemented in
order to improve patient care and ensure proper steps were taken during smart pump
integration.
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Table 2.2 Evidence Table by Category
Smart Pump Champions/
Continuous Quality

Education

Organizational Culture; Medication Errors

*Orto, Hendrix, Griffith, &
Shaikewitz, 2015.

*Gavriloff, 2012.

*Reston, 2013.

Kunde, 2015.

Catlin et al., 2015.

Kirk & Cookson, 2013.

Agyemang & While, 2010.

*Elias, Moss, Dillavou, Shih, & Azuero,
2013.

*Mariani, Cantrell,
Meakim, & Jenkinson,
2015.

Williams, 2015.

*Harding, 2012.

*Ohashi, Dalleur, Dykes, & Bates, 2014.

Glickman & Orlova, 2015.

*Murdoch & Cameron, 2008.

Elias, Moss, Shih, & Dillavou, 2014.

Harter, 2015.

ISMP, 2013; Best practice for IV medication
infusion.

*AAMI, 2014.

Smart Pump Evaluation & Surveillance
Methods
*Tan, Nhi, Kong, MacMillian, & McGain,
2013.

*Skledar et al., 2013.
Lee, 2015.
*Waterson, 2013.
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*ISMP, 2009a: Guidelines for
smart infusion pumps.

Crimlisk, Johnstone, &
Sanchez, 2009.
Munn, 2016.

Vanderveen, 2010.

*Breland, 2010.
*Dennison, 2007.
*Wiest, Longshore, & Harger,
2010.

Landi, 2016.

Vanderveen, 2014.
*Kirkbride & Vermace, 2011.

*Vitoux, Lehr, & Chang, 2015.
*IOM, 2011: Standards for developing safe guidelines.

*Goulding & Bedard, 2015.
*Carlson, Johnson, & Ensign, 2015.

Wulff, Cummings, Marck, & Yurtseven, 2011.
*Rothschild et al., 2005.

*ISMP, 2009b; IV medication safety.
*Manrique-Rodriquez et al., 2012.
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In 2010, Skledar, Niccolai, Schilling, Costello, Minni, Ervin, and Urban (2013)
initiated a CQI to monitor 6,000 smart pumps in 14 inpatient facilities to increase patient
safety. Skledar et al. (2013) offered evidence that a smart pump CQI program was useful
for increasing IV medication administration safety. By posting the hospital's CQI
findings on the intranet regularly, updating the facilities' smart pump drug libraries on the
first of each month and as needed, providing staff education as necessary, and identifying
other issues over the course of three years, the facility's compliance score increased to
78% (Skledar et al., 2013).
Implementing smart pumps in hospitals requires assistance from the hospitals'
stakeholder's, project managers, and pharmacies (Waterson, 2013). Waterson (2013)
suggested that including hospitals' stakeholders, having a continuous nursing education
program, and a champion committed to coordinating the smart pumps' information was
an effective approach.
Adopting a CQI was important; however, guidelines should be set in place to
ensure the safe implementation and use of IV smart pumps (ISMP, 2009a). The ISMP
(2009a) suggested an interdisciplinary team (e.g., nursing champions, a pharmacy, an
information technology team, biomedical engineers, and infection control) when drug
libraries are developed. Breland (2010) also performed a CQI from Spring of 2005
through May of 2006, which included end-user training sessions on April 24th and 25th
in 2006. The CQI process was used during the planning, implementation, and post
implementation phases of the project with compliance scores ranging from 33% to 39%
from November, 2006 through February, 2007 (Breland, 2010). After managing to
encourage the hospitals' nursing leaders and managers to get on board to express the
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importance of using the safety software, updating their drug libraries, and providing their
staff nurse’s real-time feedback, their compliance rate increased to 97% (Breland, 2010).
On the other hand, Wiest, Longshore, and Harger (2010) implemented a
medication administration team (MAT) that consisted of nurses, pharmacy staff, and
information technology team. The team was responsible for implementing smart pumps
within five hospitals and ensuring that each hospital had sufficient resources to reach a
compliance goal of 85% (Wiest, 2010). Wiest (2010) reported the initial scores were 6888% among the eight hospitals and ranged from 73-93% during the six-month evaluation
period with the use of the MAT team. Also, Wiest (2010) highly suggested that real-time
monitoring increased nurses' compliance to using the drug libraries, which improved
patient safety and medication administration by preventing harm.
Education
Understanding the "whys" of using Guardrails™ on smart pumps is important, as
postulated by Gavriloff (2012). Gavriloff (2012) performed a Deming Cycle that included
four stages: plan, do, study, and act. The cycle consisted mostly of communication to
nursing staff on the importance of compliance to using drug libraries (Gavriloff, 2012).
Gavriloff's (2012) method increased nurses' awareness and adherence to the IV smart
pump's medication safety software. In turn, it also increased their compliance score from
85% to 100% compliance.
Mariani, Cantrell, Meakim, and Jenkinson (2015) performed a simulated learning
scenario experience for Bachelors of Science in Nursing (BSN)-prepared nursing students
to assess nurse's perspective when delivering direct patient care. A pre-and post-survey
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was completed, and students reported that they were more comfortable with providing
direct patient care more safely after the simulated experience (Mariani et al., 2015).
Although this study was limited to BSN nursing students, Mariani (2015) suggested
further research was needed to validate simulated strategies as useful for teaching safety
and quality in nursing. Dennison (2007) educated nurses on the safety of medication
administration via computer modules over a six-month period. Dennison's (2007)
education program suggested that administrative support is imperative for fostering any
change in staff's behavior with medication administration. Dennison (2007) also suggest
recruiting an informal champion as a resource for continuous education on medication
safety administration.
Organizational Culture & Medication Errors
For any facility to be successful when adopting and implementing software, all
stakeholders should be involved with decision making for evaluating, operating, and
educating staff on the use of the technology (Reston, 2013). An organization's culture and
hospital-specific practices determined how successful they will be (Reston, 2013).
Ohashi, Dalleur, Dykes, and Bates (2014) suggested that organizations standardize their
compliance methods by upgrading and standardizing their drug libraries, thus decreasing
unnecessary pump warnings since smart pumps were useful for reducing IV medication
errors, yet look to eliminate end-users' programming errors. Murdoch and Cameron
(2008) reviewed numerous studies on IV medication errors and smart pumps. The authors
identified that smart pumps have a significant impact on increasing patient safety by
preventing programming errors if organizations customize their drug libraries and set
hard limits on smart pumps (Murdoch & Cameron, 2008).
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Vitoux, Lehr, and Chang (2015) identified ways in which organizations could go
about improving the use of their smart pump drug libraries. They strongly suggested that
the organization's culture, values, and beliefs about practice impact the integration
process of smart pumps, as it requires a team approach and the availability of a diverse
variety of stakeholders coming together for the good of collectively integrating
technology systems and devices to improve patient safety (Vitoux et al., 2015). The
Institute of Medicine (IOM, 2011) suggested that health care professionals should follow
all established guidelines and standards set in place at their facilities. Doing so will assist
in eliminating poor compliance rates and decreasing the risk of IV medication errors
occurring (Rothschild, Keohane, Cook, Orav, Burdick, Thompson, and Bates, 2005).
Rothschild et al. (2005) suggested that behavioral factors improved compliance and
medication safety. On the other hand, Rosenkoeter, Bowcutt, Khasanshina, Chernecky,
and Wall (2008) suggested considering staff nurse's perceptions on the use of smart
pumps. In general, organizations should address their culture, their nurse's behavior and
attitudes, and take a team approach when smart pumps are integrated into their facilities
(Rosenkoeter et al., 2008).
Smart Pump Evaluation & Surveillance Methods
In compliance with the use of smart pump drug libraries, the reason for bypassing
its safety feature should be measured, and barriers should be identified and removed
(ISMP, 2009b). Evaluating the use of Guardrails™ on smart pumps is an effective way to
monitor and identify barriers to its use (Tan, Nhi, Kong, MacMillian, and McGain, 2013).
Tan et al. (2013) established a smart pump surveillance method, which included the use
of an auditor to monitor nursing end-user use of drug libraries on IV smart pumps. When
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nursing end-users were found in noncompliance to the use of drug libraries during the
auditing period, auditors were required to educate nurses on any concerns regarding the
use of drug libraries, which also allowed auditors to identify potential barriers to its use
(Tan et al., 2013).
Contrarily, Elias, Moss, Dillavou, Shih, and Azuero (2013) suggested
implementing the evaluation of the use of smart pumps via a simulated environment to
obtain a much broader understanding of how human factors may impact nurses' use of
smart pumps. Conversely, Harding (2012) performed a CQI project that incorporated
monitoring quantitative data from smart pumps while utilizing both nursing staff and
pharmacy to implement new interventions aimed to increase the use of smart pumps' drug
libraries. Doing so, Harding (2012) was able to double nurses' use of smart pumps' drug
libraries over a four-month period. Kirkbride and Vermace (2011) identified ways to
utilize data reports from their smart pumps to improve clinical practice by standardizing
all of their smart pumps and developing what they called a parental infusion device
coordinator (PIDC) to perform routine quarterly reports to email to staff, attending staff
meetings and annual competencies, and performing compliance rounds to increase
nursing staff's use of drug libraries.
Goulding and Bedard (2015) performed a retrospective analysis on drug library
compliance reports over a five-month period. They identified that it was imperative that
critical care nurses take part in amending and creating their smart pumps' drug libraries
and review their CQI reports, to assist with potential education needs, improve their
clinical practice, and measure outcomes related to medication errors, patient outcomes,
and cost analysis. Carlson, Johnson, and Ensign (2015) developed a safety score used to
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evaluate 22 hospitals' use of smart pumps to decrease the number of pump alerts. The use
of basic infusion mode and the use of hard limits (e.g., end-user’s not allowed to proceed
with overriding IV medication rate and limits set forth by the institution; ISMP, 2012)
and soft limits (e.g., end-user has the choice of overriding IV medication rate and limits
set forth by the institution; ISMP, 2012) were three measures used in Carlson et al.
(2015) evaluation method. Results revealed that, after adjusting and implementing 117
new pumps within the facilities, and evaluating trends each month, the overall safety
scores among the 22 hospitals had improved from 6.41 to 7.57 (Carlson et al., 2015).
Manrique-Rodríguez, Sánchez-Galindo, Fernández-Llamazares, López-Herce,
Echarri-Martínez, Escudero-Vilaplana, & Carrillo-Alvarez (2012) were able to identify
that, after updating their drug libraries, then initiating and analyzing a Guardrails CQI
event reporter program, their compliance was 87% over of the course of the first four
months, suggesting that end-user training and readjusting of smart pump limits to
correspond to clinical practice were warranted. In a different manner, Montague, Asan,
and Chiou (2013) smart pumps’ surveillance method utilized nursing end user's
perceptions (e.g. end user’s trust) on the use of smart pumps as an evaluation tool to
assess how smart pumps may influence nurse use and trust in utilizing the technology.
Montague’s et al. (2013) research resulted in a trust score of (mean 2.97, SD 1.49),
indicating that 68% of nurses trusted smart pumps, while 14% did not and 17% were
neutral. Overall, the recommendation was that smart pump design (e.g. device speed,
reliability, learnability, noise, alarm, navigation, and automation transparency) influences
the nurse's trust in the device.
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Findings from Hospital-Wide Survey Conducted at the Clinical Site of This Project
Following review of the literature, the AGT looked at data from the hospital-wide
survey conducted in January, 2015. All nurses who administered IV medications in the
hospital system received a survey (N=2,500). The survey contained five questions: What
is the primary unit that you work on and which of the following are reasons that are
barriers to your using Guardrails™ safety features on the Alaris® smart pumps? One
hundred nineteen surveys were returned. Table 2.3, Summary of Hospital-Wide Survey
Data identifies the specific barriers.
A variety of authors recommended the use of an implementation team when
adding smart pumps and drug libraries to a facility. The facility had already formed the
AGT which included all of the necessary professional groups. Analysis of the data from
the hospital-wide survey indicated that the majority of nurses (N=85) did not use the
Guardrails safety features because they could not find the drug or the drug was missing
from the drug library. This finding is consistent with the literature. In response to the
survey data, the AGT implemented four interventions designed to improve the use of the
Guardrails safety features.
Based on this data, Intervention 1 was the development of a drug library that more
closely matched those used in the facility and a reorganization of drugs to make them
easier to find. The AGT realized that maintenance of the drug library needed to be an
ongoing process. Thirty nurses said that using the technology was tedious and did not
match the workflow of their unit. Intervention 2 was to acknowledge that the
organization's culture influenced adoption of technology. The creation of an Alaris
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Guardrails™ Audit Champions (AGACs) influenced the nursing staff to adopt a culture
of change within the organization. A few nurses indicated that they did not received
proper training. Intervention 3 was to add smart pump training to the new employee
orientation program. Intervention 4 was to establish an effective smart pump
evaluation/surveillance system while implementing CQI champions.

Table 2.3 Summary of 2015 Survey Data
Drug isn’t
in Library

I can’t
find the
drugs I
need

No time/
tedious

No
training/
education

Guardrails™
does not
match work
flow

63

22

8

9

30

Reasons

Number of
responses

Other
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Note. Nurses could choose all that applied.

Barriers to Implementation
Changing nurse behaviors in relationship to the use of smart pumps with
Guardrails™ has the potential to be very challenging. This quality improvement project
has the advantage of using evidence-based interventions gleaned from the literature. All
of the stakeholders fully engaged should help in behavior change. Ongoing evaluation
will help the AGT to monitor progress and identify barriers that may arise during the
project.
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Summary
After determining that the facility's compliance scores on use of Guardrails™ by
nurses were less than the benchmark in February of 2015, the hospital's stakeholders and
members of the nursing staff were able to establish the AGT who led the process of
promoting use of smart pumps and Guardrails™ safety features by nurses. Chapter III
presents the methods used to implement the quality improvement project.
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CHAPTER III
METHODS

Chapter III provides information on the methods used to implement the quality
improvement project. Doing so, the project's design, sample, setting, interventions,
instruments, procedure, and data analysis were all explored in this chapter.

Design

A one sample pre- and post-survey design was used to identify factors that
influence the use of Guardrails™ since the implementation of various interventions that
started in 2015.

Sample

The project sample consisted of 2,500 nurses who administer IV medications
using smart pumps with the Guardrails™ safety feature in the facility. All levels of nurse
education were included except for License Practical Nurses (LPNs). Both male and
female nurses who work full-time, part-time, and as needed (PRN) participated. All
travelers who contracted with the institution were excluded, as only core staff were
included in the project. Managers were not included, and nurses were excluded only if
they do not employ the IV smart pumps at the facility.
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Setting

The quality improvement project occurred in South Carolina at a facility
recognized as Magnet®. The institution maintains 58 inpatient and outpatient settings
that utilize IV smart pumps with Guardrails™. There are approximately 740 licensed
beds in the four hospitals managed by the facility.

Interventions

The AGT was established to develop interventions aimed to increase nurses'
awareness, knowledge, and adherence to Guardrails™ safety features on smart pumps.
The interventions were based on evidence from the literature, organizational assessment,
and data from the hospital-wide survey conducted in 2015.

Intervention 1

The AGT added smart pump training to the new graduate and new hire
orientations. The team also created a Guardrails™ website; placed a quick reference
guide on the facility's intranet as a resource for staff nurses; and produced Guardrails™
education videos. In addition, education workshops were held for both nurses and
managers at various times throughout the year.

Intervention 2

Based on the hospital-wide survey in 2015, the pharmacy re-organized and
combined the drug libraries for a more customized universal approach that best suited the
organization's culture and clinical practice. Updates to the drug libraries were done
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quarterly rather than every six-months. Continuing education, library updates, and
customization improve compliance (ISMP, 2009a).

Intervention 3

According to Orto et al. (2015), a pump champion program is valuable for
improving nursing compliance to drug libraries, and it is vital that the collaboration be
done with the hospital's pharmacy leadership, as well as medication safety personnel. The
AGT piloted a smart pump audit champion on an adult critical care unit to assess the
feasibility of implementing an audit champion throughout the entire facility. The audit
champion performed three to five audits on nurses' adherence to Guardrails™, and
ensured nurses entered the correct unit identifier (ID) number into the smart pumps for
appropriate data retrieval for the pharmacy. The champions were selected for both the
day and night shift and were responsible for auditing a total of 15 smart pumps per week.

The champion's role also consisted of educating nurses on the importance of using
Guardrails™ and reinforcing the significance of placing the unit's ID number into the
smart pumps. Monthly data reports were projected to be given to each unit's manager,
who would emphasize the legal liabilities associated with being noncompliant to
Guardrails™ on smart pumps. The pilot was a success, and the champions provided
useful feedback, suggesting the use of a paperless audit tool, and decreasing the number
of audits collected every week. Finally, the Alaris® Guardrails Audit Champions
(AGAC) were established and rolled-out throughout various areas within the facility,
beginning with critical care. The AGAC process promoted cultural change on the use of
Guardrails™.
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Intervention 4

Continuous monitoring by the AGAC and Guardrails™ compliance data were
performed monthly. Adjustments to the audit process were based on feedback from each
area's champion and their managers before reassessing the need to roll-out to the next
consecutive area each month. Overall, the current audit process positively impacted
nurses' awareness and adherence to Guardrails™ on smart pumps.

Instruments

Outcomes were measured using a hospital-wide survey developed by the facility
based on the survey distributed in 2015, informal interviews with several key
stakeholders, Guardrails™ data percentage compliance rates retrieved monthly from
CareFusion®, but aggregated as yearly statements on self-reported IV medication errors
and near miss data reports retrieved from the institution's quality department and
extracted into Excel® software.

Hospital-Wide Survey 2017

The Hospital-Wide Survey 2017 was created using the Redcap software.
Therefore, “this project was supported by NIH/NCRR Colorado CTSI Grant Number
UL1 RR025780. Its contents are the authors’ sole responsibility and do not necessarily
represent official NIH views” (Harris, Taylor, Thielke, Payne, Gonzalez, Conde, 2009,
para 4). Redcap offers a variety of analytical options for interpreting the inquiry results.
All information from the survey was collected in Redcap and held under strict security
and confidentiality. Both the project's author and a statistician had full access to the
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survey results in Redcap. The Redcap software allowed survey response to be completely
anonymous by selecting the Public Survey Link under the Manage Survey Participant
option to ensure responses were kept anonymous, and blinded to the projects’
investigators. Participants were invited to take the survey via email, and the information
received from each survey response was automatically downloaded into the Redcap
software.

The Hospital-Wide Survey 2017 was extracted in whole from the inquiry
conducted in 2015. The same survey used in 2015 was also used in 2017 for appropriate
comparison. The 2015 survey contained five questions. The first question asks the
participant to identify the unit they primarily work on. The second question asks the
participants to check all the barriers that apply to the use of Guardrails safety features on
smart pumps. There were six barriers: The drug is not in the library, I cannot find the
drug I need, There is no time/it is tedious, There is no training/education, and
Guardrails™ do not match the work flow. Participants had the option to choose all that
apply, and respond with comments to any of the six barriers.

Feedback from the survey was provided to hospital administrators and nursing
staff. The responses received from the survey provided insights to make appropriate
recommendations for the institution. Thank you notes were sent out to everyone from the
original email list after the survey closed.
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Interviews with Stakeholders

Throughout the course of the project, several key stakeholders were informally
interviewed at various times. Those interviewed included a nursing informatics director, a
human factor engineer, and a pharmacist. The nursing informatics director was shadowed
for five months during the project. The interview with the informatics director was
informal, and all information obtained from the director was used as a reference for
contacting other key leaders needed to collect appropriate data to assess how smart
pumps and Guardrails™ were used at the facility.

Second, a human factor engineer was interviewed. Again, the interview was
informal. Inquiries regarding barriers to nurses' use of Guardrails™ on the smart pump
were addressed. Significant information was obtained, and factors such as body
mechanics, age, height, device malfunction, and the overall design of the user interface
were identified as potential barriers to the use of smart pumps. Finally, the pharmacist
interviewed was a member of the AGT and provided pertinent information about the
history of smart pumps at the institution and information on data collection on
Guardrails™ usage.

Percentage of Guardrails™ Usage

The proportion of Guardrails™ usage by nurses was captured every month from a
measuring tool used by CareFusion®, the makers of the Alaris® pumps. CareFusion®
sends data to the institution based on their Guardrails™ usage as compared to other
facilities that use smart pumps from CareFusion®. The tool supplies the facility with a
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monthly count of infusions using the Guardrails™ Suite MX and those not using the
Guardrails™ Suite MX. The information is captured, and a percentage of usage score is
calculated. The reports were sent to the pharmacy department every month, and
pharmacy would run the reports via the hospital's web server. Later, the pharmacy would
send the information to the AGT.

Self-reported IV Medication Errors

The quality department collected information on medication errors and near
misses as they were all self-reported by staff at the facility through the hospital's patient
safety net (PSI) reporting portal. The data retrieved from the reporting tool was converted
using Excel® software for review as needed. Reports from the application provide data
monthly. For this project, however, compliance reports were obtained monthly, but
aggregated as yearly accounts.

Procedure

The procedure for this quality improvement project is described below. First, the
institutional review board was notified about the quality improvement project to obtain
valid institutional approval. Second, interventions 1-4 were implemented over a 2-year
period. Third, one week before the survey was distributed, managers were instructed by
the hospital’s Assistant Chief Nursing Officer (ACNO) to reinforce to staff nurses the
importance of taking the survey to gain a high response rate to take part in the survey.

Since Sunday was the start of the work week at the facility, the survey was sent
out on the following Friday, September 15, 2017. The survey was made available for
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voluntary participation for 2 ½ weeks to ensure all staff nurses would have allocated
enough time to complete the survey. The participants were encouraged by their unit’s
manager to complete the survey before the 2 ½ weeks deadline. All participants were sent
a friendly reminder on the Sunday after the survey opened that states, “work with the
survey will be ending soon, please complete the survey and send, thank you.” The
rationale for taking the survey was provided to each participant and presented at the
beginning of each survey invitation. Instructions presented in the survey offered
information, suggesting that the nine-question survey will take less than five minutes to
complete, and feedback from the survey will assist in making the medication
administration safer at the facility. In effort to thank all the participants that were invited
to take part in the survey, a "thank you" note was broadcasted via email to all participants
from the original email list after the survey closed. Completed surveys were
automatically downloaded to the Redcap software where the results were analyzed.

Interviews

Several stakeholders were informally interviewed at various times throughout the
quality improvement project. First, a pharmacist was interviewed and used as a reference
at different intervals throughout the project. The pharmacist was asked to provide data on
Guardrails™ utilization, information on medication administration times/schedules, and
information on the historical evidence pertaining to the initiation of smart pumps at the
facility. The pharmacist also volunteered information about their wireless system and
how data from the smart pumps is captured from each unit monthly. The pharmacist
indicated that the institution lacks an effective strategy to capture the data from specific
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units. Therefore, it was difficult to track compliance information from each unit. Thus,
the creation of a AGACs served as a resource for nurses on the unit. The AGACs
assessed 10-15 smart pumps per week to verifying that both Guardrails™ and the correct
unit number are programed into the smart pumps. The AGAC then placed the information
collected during their visual inspection into the facilities audit tool available online via
Verge software. The AGAC also served as a direct resource for educating nurses on the
importance of adherence to Guardrails™ and placing the unit’s number into the smart
pumps. Overall, communication with pharmacy had been ongoing via email as questions
about the project evolved.

The nurse informatics director was then interviewed. The informatics leader was
shadowed for a course of five months during the project. The informatics director served
as a resource for allocating information needed from various stakeholders in the facility.
The informatics director offered a broader insight into the cost analysis associated with
smart pumps and how cost played a major role in setting priorities in the institution. The
informatics leader insisted that due to the facilities' current priorities, the decision to
purchase the pump-integrated system with the smart pump connected to electronic health
record (EHR) was not a feasible solution for the institution at this time. Integration of the
smart pumps into the EHR offered the facility a solid solution to the automatic extraction
of unit-specific smart pump data for tracking and auditing instead of having nurses
manually program their unit-specific ID number into the smart pumps. This would enable
the pharmacy to create unit-specific compliance reports.
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Lastly, a human factor engineer was also informally interviewed. The engineer
offered new insightful information on the use of smart pumps. The engineer identified
potential human factors that are barriers to the use of Guardrails™. Factors include the
age and height of the nurse that potentially contribute to the efficient use of the smart
pumps. Other factors include malfunction of the smart pump devices and the design of
the user interfaces on the smart pumps. The three members interviewed were beneficial
with providing information needed to complete this project.

Data Analysis

The data allocated for this project included results from both the 2015 and 2017
surveys and Guardrails™ compliance data rates compared to self-reported IV medication
errors from 2015 to 2017. A one-sample t-test was used to analyze and compare both the
2015 and 2017 survey results. The outcome was measured from 2015 to 2017, and
Guardrails™ usage rates and self-reported IV medication errors were compared using a
two-sample portion z-test. The information collected and analyzed in this quality
improvement project offered a systematic organizational assessment to identify factors
that influence the use of Guardrails™ by nurses, so that recommendations for future
change could be made in order to foster continued progress toward the benchmark set by
the facility of 90-100% of the time.
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CHAPTER IV
RESULTS

Chapter IV presents the results from the practice improvement project. The EBP
question that guided this project was, “For hospital based nurses using smart pumps with
Guardrails™, what are factors that influence the use of smart pumps with Guardrails™
after implementing interventions based on the 2015 systematic organizational assessment
and hospital-wide survey as measured by 2017 hospital-wide systematic organizational
assessment and survey, percent of use of Guardrails™ by nurses, and self-reported IV
medication errors per month. Both the 2015 and 2017 surveys were created and
administered using Redcap software. After the survey closed, all data were downloaded
to Excel® and analyzed using SAS statistical software (version 9.4).

Descriptive statistics were used to analyze and interpret data collected from the
project. Barriers to use of Guardrails™ with smart pumps from the 2015 survey were
compared to barriers reported in the 2017 survey following the interventions.

Self-reported IV Medication Errors

Data on self-reported IV medication error were collected from the institutions
quality department and downloaded for analysis into Excel® software. SAS analysis was
used to compare nurses’ use of Guardrails™ before (2010-2014) and after
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(2015-2017) the interventions. A z-test was used to analyze the data. The p-value was
significant at.00001. The proportion of nurses using Guardrails™ on smart pumps was
significantly higher (.81) after the interventions than before (.71). Table 4.1 presents
these data.

In 2008, IV smart pumps were integrated at the facility to decrease the risk of IV
medication errors. In 2010, there were approximately 978 reported cases of IV
medication errors at the facility (Figure 4.1). In addition, Figure 4.1 shows data on the
count of self-reported IV medication errors recorded from 2010-2017. Guardrails™ were
then added to the smart pumps in April of 2010, with a compliance goal set at 90-100%.
However, the facility identified that nurses’ used Guardrails™ less than 75% of the time
(Figure 4.2).

Use of Guardrails™

Data on Guardrails™ utilization rates were collected from pharmacy and exported
to Excel® and yearly utilization rates were calculated. A yearly account of Guardrails™
utilization scores is displayed in Figure 4.2. Guardrails™ utilization scores continued to
decline in 2011 and 2012. Scores averaged 69% (Figure 4.2). In 2013, scores averaged
74% and 75% in 2014. The practice improvement project began in 2015. As of
September 2017, the average utilization rate of Guardrails™ was 88% for the year, and
90% for the month.

Guardrails™ utilization and self-reported IV medication errors were reported
from 2010-2017 were captured using Excel® analytical tools. The information was
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generated based on yearly averages of both Guardrails™ utilization and accounts of selfreported IV medication errors by year. The report revealed that in 2011, self-reported IV
medication errors had reached its peak of 1529 reported cases compared to low
Guardrails™ utilization score of 69% (Figure 4.3).

Table 4.1 Guardrails™ Score Pre and Post
Total number of
Guardrails™

Proportion of
Guardrails™

Observations

Total
number
Infusions

2010-2014

12812959

9140165

.71335

2015-2017

4935361

3988099

.80807

variances

Z test statistics

P-value

5.4042E-8

-407.423

.00001

Proportion Test Results

1800

Self-reported IV Medication Errors 4/2010 to
3/2017
1529
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Figure 4.1. All Self-reported IV Medication Errors 4/2010 to 3/2017
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0%

In contrast, by 2015 there were 1108 reported cases of self-reported IV
medication errors, and Guardrails™ utilization scores averaged 76% (Figure 4.3).
Guardrails™ utilization increased by 10% in 2017 and self-reported IV medication errors
decreased. There were 235 reported cases of self-reported IV medication errors as of
March 2017 (Figure 4.3). A retrospective view of Guardrails™ utilization over-time is
displayed in Figure 4.4. Figure 4.4 also illustrates Guardrails™ utilization before and
after the AGT initiated the practice improvement process in March of 2015. Utilization
scores averaged 74%-75% in 2014 before the AGT was established in 2015, while
current compliance scores as of September 2017 averaged 88%.

2015 Pre-Survey Data

The pre-survey was conducted in January of 2015 (N=119). The data collected
from this survey provided insights on barriers to nurse’s use of Guardrails™ on smart
pumps. Figure 4.5 illustrates the proportion of participants who completed the survey
based on specific nursing areas. Question 2 on the survey asked, “What unit do you
primarily work on?” Data collected from the responses to question 2 were categorized
using themes based on all nursing areas identified in the survey. Codes were established
in Table 4.2. The codes created in Table 4.2 were used to interpret various data
throughout this project. Each category were identified based on responses from the
survey. Themes were created as they related to the specific areas in each category. Each
code, MS, C, M, I, S, and P, represents its corresponding nursing area listed from each
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theme (e.g., MS= All Medical/Surgical Floors, C= Critical Care, M= Meduflex Float
Pool, I= Infusion Cancer Center, S= Specialty Areas, P=Pediatrics).

Guardrails® Utilization
100%
95%
90%

Improve
Process Begin
March 2015

85%
80%
75%
70%
65%
60%
55%
50%
Jan-15

Jul-15

Feb-16

Aug-16

Mar-17

Sep-17

Figure 4.4 Guardrails™ Utilization Over Time
Table 4.2. Key for Nursing Areas
Survey Key for Nursing Areas
Category
Cardiovascular, GI, Renal/Transplant,
Oncology, Neurology, Ortho, Stepdown
units, Transitional Care units,
ED, PACU, all Adult ICU’s
Critical Care both Pediatrics and Adults,
Med/Surg. Floors
Infusion Cancer Center
Transplant Infusion, Senior Care Unit,
Heart and Vascular Prep/Recovery, Cath
Lab, Interventional Radiology, Adult
Cardiovascular Clinic
Pediatric ICU’s, Special Care Nursery,
Mother Baby, Med/Surg. units

Theme

Code

All Medical/Surgical Floors
Critical Care

MS
C

Meduflex
Infusion Center

M
I

Specialty Areas

S

Pediatrics

P

*Note. GI= Gastroenterology, ED =Emergency Department, PACU =Post Anesthesia Care Unit, ICU =
Intensive Care Units.
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The percentage of nurses who completed the survey from various nursing units is
presented in Figure 4.5. The information in Figure 4.5 reveals that of 119 participants,
50% (n=60) were from various Medical/Surgical nursing areas both impatient and
outpatient. Twenty percent (n=24) were from Critical Care, 8% (n=10) were from the
Infusion Cancer Center, and 12% (n=14) were from various Specialty care areas, and 7%
(n=8) were from Pediatrics. Results from the pre-survey are presented in Table 4.3 as a
frequency table. Question 3 of the pre-survey identified barriers to nurses’ use of
Guardrails™ by providing each participant six check all that apply options.
There were (N=119) responses, 52.94% (n=63) of participants agreed that drugs
are not available in the library, 18.49% (n=22) agreed that they have trouble finding the
drugs in the drug libraries, 6.72% (n=8) agreed that they don’t have enough time/using
Guardrails™ is tedious, 7.56% (n=9) agreed that they never received training or
education on using Guardrails™, 25.21% (n=30) agreed that existing Guardrails™
setting did not match their workflows in their work areas, and 15.97% (n=19) agreed
there were other issues which prevented them from utilizing the Guardrails™ features.
Survey questions 4, 5, and 6 extended from question 3 of the survey and provided
the option for participants to write-in comments. Question 4 in the pre-survey asked, “If
you selected, I am having trouble finding the drugs I need in the different Guardrails™
libraries, please tell us which drug(s) you are having trouble finding and which libraries
you use.” Information presented in Figure 4.6 is based on written responses to question 4
by nursing areas.
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2015 Pre-Survey Responses By Nursing Areas
7%

3%

12%

All Medical/Surgical Floors
Critical Care
Infusion Cancer Center

50%

8%

Specialty Areas
Peds-both cc/floor
Meduflex-both P/A

20%

Figure 4.5 2015 Pre-Survey Participants

Table 4.3 2015 Pre-Intervention Barriers

Variables*

2015 Pre-Survey Question 3: Barriers

I have
looked/asked
and the drug I
need isn’t in
the Guardrails
library

I am having
trouble
finding the
drugs I need
in the
different
Guardrails
libraries

N

%

N

%

No

56

47.06

97

81.51

Yes

63

52.94

22

18.49

I don’t have
enough time to use
Guardrails/using
Guardrails is
tedious

N

I didn't
receive
training or
education
on using
Guardrails

%

N

%

111

93.28

110

92.44

8

6.72

9

7.56
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Existing
Guardrails
settings
don't match
with
workflows
in my area
N

Other

%

N

%

89

74.79

100

84.03

30

25.21

19

15.97

Nursing Areas with Written Responses to
Question 4
70%
60%
50%
40%
30%
20%
10%
0%

60%

19%
7%

3%

10%
0

1
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All Medical/Surgical Floors

Critical Care

Meduflex -both P/A

Infusion Cancer Center

Specialty Areas

Peds- both cc/floor

Figure 4.6 Percent of Written Responses to Pre-Survey Question 4

Only 58 participants provided comments on survey question 4. Sixty percent
(n=35) were from Medical/Surgical Floor areas, 19% (n=11) were from Critical Care
areas, 3% (n=2) were from Meduflex areas, 7% (n=4) were from Infusion Cancer Center
areas, and 10% (n=6) were from all inpatient and outpatient Specialty areas. There were
(n=0) written responses to question 4 from Pediatrics areas. The information captured in
Table 4.4 was extracted in whole based on participants written responses to question 4.
Each nursing unit responses were categorized by areas and codes were established for
each unit. The legend for Table 4.4 is illustrated in Table 4.2.

Question 5 from the survey asked, “If you selected I have looked/asked and the
drug I need isn’t in the Guardrails™ library, and please tell us which drug is/are
missing.” Information pertaining to question 5 evoked several key responses. The data
presented in Figure 4.7, reveals all survey participants who responded in written form to
question 5 (n=15). There were 73% (n=11) responses from participants in
Medical/Surgical Floor areas, 13% (n=2) from Critical Care areas, and 13 % (n=2) from
all Specialty areas. There were no responses from Pediatric, Infusion Cancer Center, or
Meduflex nursing areas. All written responses to question 5 were extracted in whole and
displayed in Table 4.5 based on nursing areas. Table 4.2 provides a legend to identify
each nursing unit code.

Question 6 asked, “If you selected other, please tell us what any other barriers to
using Guardrails™ are?” Of the 19 responses, 47% (n= 9) written comments were from
participants on the Medical/Surgical Floors areas, 21% (n=4) from Critical Care areas,
5% (n=1) from Infusion Cancer Center areas, 16% (n=3) from Specialty areas,
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Table 4.4 Written Responses to Pre-Survey Question 4
Nursing
Unit
Category

C

I

M

MS

S

Written Response to Survey Question: 4
Azithromycin
Banana bag w/ thiamine
Keppra
Keppra, citate for CRRT
Lots of ab1, some chemo drugs
Magnesium. Also, mag given for resp distress should be 2g in 15 minutes; for mag
replacement, should be 1-2 hours
Some ab1 we use
Trane1amic acid
Vimpat
Ab1, drugs that need to be titrated, and chemo regiments like cytarabine and cyto1an
Can't remember
Dose appropriate - cyto1an, cytarabine - I have to program outside of the soft stop for
most non-RCHOP/BMT uses
They have since been updated
Alteplase
Don't remember
Ab1 - will try to remember which one and write down
Ab1 but can't remember the name
Alteplace for IR lytics (dose usually 1 mg/hr - drug, 5 mg/250mL bag, 50 mL/hr). Also,
alteplase for use with EKOS system. Drug concentration 10 mg in 250 mL run at 25
mL/hr. This is per manufacturer of EKOS machine due to the low flow and high
pressure needed to push the TPA to the clost. EKOS coolant of normal saline also needs
to run at 35 mL/hr.
Can't remember
Certain chemo regimens
De1amethasone, ondansetron, bolus fluids
DHE
DHE and some ab1
Don't remember
IV levetiracetam, 0.45% sodium chloride
Keppra
Keppra, Vimpat
Kytril
Lasi1
Levaquin
Multiple ab1
Octreotide
Ondansetron (zofran), ceftria1one (Rocephin); I would recommend adding common
combo chemos, like etoposide/adriamycin/vincristine if possible
Phenergan
Sodium bicarb
TPN
Uncommon ab1
Zithroma1
Zofran
Zofran/odansteron, furosemide/lasi1 (correct dosage or ability to change is not in there)
Adenosine gtt for FFR
Alteplase
Alteplase for EKOS
Can't remember e1actly right now, but common ab1
Sodium phosphate
Thiamine
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Nursing Areas with Written Responses to
Question 5
Peds- both cc/floor 0
Specialty Areas
Infusion Cancer Center

13%
0

Meduflex -both P/A 0
Critical Care

13%

All Medical/Surgical Floors

73%
0%

10%

20%

30%

40%

50%

60%

70%

80%

Figure 4.7 Percent of Written Responses to Pre-Survey Question 5
Table 4.5 Written Responses to Pre-Survey Question 5
Nursing Unit
Category

C

MS

S

Written Response to Survey Question: 5
I don't see any trouble with the library, I just don't like the pumps period. They
are awful and need to be replaced with better overall pumps.
Same
IVIG
1
Amiodarine bolus
Azactam is not in peds critical care <20 kg
Due to previous e1perience
IV levetiracetam, 0.45% sodium chloride
Keppra
Ondanestron, combo ondensetron/de1amethesone, combo
etoposide/do1orubicin/vincristine
Phenergan
TPN
TPN & lipids are confusing to find

Alteplase
Can't remember
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and 11% (n=2) from Pediatric areas, which includes both intensive care and
medical/surgical Pediatric nursing areas (Figure 4.8). The information displayed in Table
4.6 was extracted in whole and includes all written comments from question 6. Table 4.2
provides a legend to identify each nursing unit code.

2017 Post-Survey

Data collected from the post-survey used both Excel® and SAS (version 9.4) to
analyze the query. There were 155 responses to the 2017 post-survey. Unlike the presurvey, the post-survey included three questions on demographics one question to assess
the facilitys’ current 2017 AGAC process. Like the pre-survey, question 2 of the post
survey asked, “What unit do you primarily work on?” The data results were then
analyzed using SAS frequency tables. Again, all data collected from questions which
contained a written response were categorized using themes based on nursing areas, and
codes were created from each unit theme (Table 4.2). There were 153 total responses to
question 2.

The data reported in the Figure 4.9 reveals that of 153 responses, 45% (n=69) of
survey respondents were from all Medical/Surgical areas, 23% (n=36) were from Critical
Care areas, 7% (n=10) were from Infusion Cancer Center areas, 1% (n=2) were from all
other Specialty nursing areas, which included both inpatient and outpatient, 7% (n=10)
were from all Pediatric nursing areas, and 17% (n=26) were from the Meduflex areas. A
representation of all newly added demographics to the post-survey are presented in Table
4.7.
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Nursing Areas with Written Responses to
Question 6
Peds- both cc/floor

11%

Specialty Areas

16%

Infusion Cancer Center

5%

Meduflex -both P/A

0%

Critical Care

21%

All Medical/Surgical Floors

47%
0%

5%

10% 15% 20% 25% 30% 35% 40% 45% 50%

Figure 4.8 Percent of Written Responses to Pre-Survey Question 6
Table 4.6 Written Responses to Pre-Survey Question 6
Nursing Unit
Category

C

I

MS

P
S

Comments: Survey Question: 6
Don't reply to me
It can be tedious for basic fluid admin. And it takes all thinking out of med admin,
which is detrimental to nursing skill development.
When a patient is crashing, I have to change over the IV pump settings to Critical
Care versus Med Surg patient. When trying to set up vasopressors this delay with
having to reset the pump is an issue.
When patients have multiple bags of potassium ordered, for the sake of continuity
and keeping infusions running, I would like to be able to program a primary
potassium infusion and piggy back a second bag of potassium as a secondary
infusion. Alaris will not let you set primary potassium and secondary potassium, you
have ot set a primary basic infusion and a secondary potassium infusion to run 2 bags
continuously over 2 hours without interruption.
Most of the drugs I've requested be added to the oncology library have been added
already
After you select medication, you have to manually plug in dose, volume, and rate I've seen other hospitals have common drugs plugged in with dose, volume, and
rate
At times the ordered dose is outside Guardrails
Have had issues with IV abx not used often on the unit
I am unsure if our pumps received the wireless update sent over the past few weeks
I have issues with secondary infusions and being able to set Guardrails. Also, maybe
some education on making sure we are choosing the right fluids. Lastly, TPN, the
dextrose is translated to % of dextrose on bag and in MAR, but on pumps it's in
grams/mL. I don't know how to convert that and most often the number I think it
would be isn't available on the selected list.
IVPBs that have more than one drug, dex, zofran etc. not on list
No barriers
No problems
None
No barriers
Have been using basic infusion due to IV being for hydration only
No issues
None that I can recall
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2017 POST-SURVEY RESPONSE BY
NURSING AREAS
All Medical/Surgical Floors

Critical Care

Infusion Cancer Center

Specialty Areas

Peds-both cc/floor

Meduflex-both P/A

17%
7%
1%
7%

45%

23%

Figure 4.9 2017 Post-Survey Response by Nursing Areas

Table 4.7 Demographic Variables
Variables

Post-Survey
(N=155)
N

%*

Age
18-28
29-39
40-50
51-61
61+

42
66
30
15
2

27
43
19
10
1

Level of Education
Associates
Bachelors
Graduate

30
110
13

20
72
8

Years of Nursing Experience
0-5
6-11
12-17
18+

86
35
16
17

56
23
10
11

*Note. All percentages in this table were reported from SAS analysis (version 9.4) and rounded to its
nearest whole number.
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Question 3 in the 2017 post-survey asked, “What is your current level of
education?” Figure 4.10 displays the distribution of education from the 153 respondents.
Twenty percent (n=30) held an Associates in Nursing, 72% (n=110) held a Bachelors in
Nursing, and 8% (n=13) held a Graduate degree in Nursing. A description of the second
demographic variable from question 4 of the post-survey is presented in Figure 4.11.
Question 4 asked, “Years of nursing experience?” Data revealed that there were 154
responses, with 56% (n=86) having 0-5yrs. of nursing experience, 23% (n=35) with 611yrs. of nursing experience, 10% (n=16) with 12-17yrs. of nursing experience, and 11%
(n=17) with 18+ yrs. of nursing experience. Age was the last demographic variable
assessed in the post-survey.

Figure 4.12 represents information extracted from responses to question 5 of the
post-survey assessment. There were 155 responses, and data revealed that 27% (n=42)
were 18-28yrs. of age, 43% (n=66) were 29-39yrs. of age, 19% (n=30) were 40-50yrs. of
age, 10% (n=15) were 51-61yrs. of age, and 1% (n=2) were 61+yrs. of age. The
frequency table presented in Table 4.8 reports information obtained from question 6 in
the 2017 post-survey. Question 6 from the post-survey asked nurses to identify barriers to
use of Guardrails™ by providing each participant six check all that apply options. Of the
155 responses, 35.48% (n=55) of participants agreed that drugs are not available in the
library, 10.32% (n=16) agreed that they have trouble finding the drugs in the drug
libraries, 12.26% (n=19) agreed that they don’t have enough time/using Guardrails™ is
tedious, 3.87% (n=6) agreed that they never received training or education on using
Guardrails™, 11.61% (n=18) agreed that existing Guardrails™ settings did not match
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their workflows, and 26.45% (n=41) agreed that there are other barriers to their use of
Guardrails™.

LEVEL OF NURSING EDUCATION
Graduate, 13,
8%

Associates, 30,
20%

Bachelors,
110, 72%

Figure 4.10 Level of Nursing Education

Years of Nursing Experience
56%

23%

0-5yrs.

6-11yrs.

Figure 4.11 Years of Nursing Experience
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11%
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43%
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Age of Participants

40%
35%
30%

27%

25%

19%

20%
15%

10%

10%
5%
0%

1%
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29-39yrs.

Figure 4.12 Age of Participants

40-50yrs.

51-61yrs.

61+ yrs.

Table 4.8 2017 Post-Intervention Survey
2017 Post-Survey Question 6: Barriers
I have
looked/asked and
the drug I need
isn’t in the
Guardrails
library

I am having
trouble finding
the drugs I need
in the different
Guardrails
libraries

No

N
100

%
64.52

N
139

%
89.68

N
136

Yes

55

35.48

16

10.32

19

Variables*

I don’t have
enough time to
use
Guardrails/using
Guardrails is
tedious

I didn't receive
training or
education on
using
Guardrails

Existing
Guardrails
settings don't
match with
workflows in
my area

%
87.74

N
149

N
137

%
88.39

N
114

%
73.55

12.26

6

18

11.61

41

26.45

%
96.13
3.87

Other
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There were 40 responses to question 7 presented in Figure 4.13. Question 7 asked,
“If you selected I am having trouble finding the drugs I need in the different Guardrails™
libraries; please tell us which drug(s) you are having trouble finding and which libraries
you use.” Results revealed that 48% (n=19) of nurses from all Medical/Surgical areas,
25% (n=10) from Critical Care areas, 20% (n= 8) from Meduflex areas, 5% (n=2) from
the Infusion Cancer Center areas, 0% (n=0) from Specialty areas, and 3% (n=1) from
Pediatric areas provided written responses to question 7 (Figure 4.13). All written
responses to survey question 7 were extracted in whole and presented in Table 4.9. The
codes for each nursing unit category presented in table 4.9 is displayed in Table 4.2.

Question 8 from the post-survey also required participants written responses.
There were 27 written responses to survey question 8. Results illustrated in Figure 4.14
provides a description on all written responses by nursing unit areas. There were 44%
(n=12) written responses from Medical/Surgical areas, 26% (n=7) from Critical Care
areas, 26% (n=7) from Meduflex area, 4% (n=1) from the Infusion Cancer Center, and 0
responses from both Pediatrics and Specialty areas. All written responses to survey
question 8 were extracted in whole and presented in Table 4.10. The codes for each
nursing unit category presented in table 4.10 is displayed in Table 4.2.

Responses by nursing areas are displayed in Figure 4.15. Question 9 asked, “If
you selected other, please tell us what any barriers are to using Guardrails™.” There were
43 written responses. The information from Figure 4.15 reveals that 42% (n=18) of all
written responses to question 9 were from all Medical/Surgical areas, 33% (n=14) from
Critical Care areas, 16% (n=7) from Meduflex areas, 7% (n=3) from the Infusion Cancer
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Nursing Areas by Written Responses to Question
7
Peds- both cc/floor

3%

Specialty Areas

0%

Infusion Cancer Center

5%

Meduflex -both P/A

20%

Critical Care

25%

All Medical/Surgical Floors

48%
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Figure 4.13 Percent of Written Responses to Post-Survey Question 7

Table 4.9 Written Responses to Post-Survey Question 7
Nursing
Unit
Category

C

I

M
MS

P

Written Responses to Survey Question: 7
DEFIBROTIDE
I can't remember
In pacu we frequently use ansethsia settings for drips, they are frequently not
avalible in nursing libraries
kcentra
Mainly IVF such as plasmalyte and things like that
n/a
NA
Several antibiotics - I always report this to my pharmacist
Standard and mixed IVF choices are minimal and/or confusing to select. When
it takes 60+ seconds to program/find a simple IVF, I am MUCH less likely to
use the guardrail settings for this infusion.
clinical trial drugs; new drugs just on market, olaratumumab, a couple of
others but cannot recall specifically at this time.
oncology avolumab is on study
adult
Cannot remember
I don't recall. I always use the guardrails. But if I don't it's because I can't find
the drug. It has been a long time since that has happened
n/a
Not sure
several; can't remember which ones
this is the only reason i would not use the guardrails, i always use them
because of a mistake i made about 8 years ago.
Adult Med/Surg library; albumin
Albumin for liver patients, rate not defined
antibiotics; chemotherapies
Blood Products
chemo drugs not present in Adult guardrail library
Desmopressin, adult drugs
I am able to find most of the drugs I need
I cant recall now but it has happened a couple of times. Search by name
I can't remember exactly.... I think it was a sodium/dextrose combo.
I dont recall
I dont remember
I have trouble deciding which category to look under for the drug/fluid I am
about to hang
I use the Oncology library. If we have to administer chemo on other floors
(ICU, cardiology) they need their own cardiology setting
IV guardrail drugs, Keppra
IVF's
n/a
past in time problem, cannot remember the name of the drug
There have been maybe one or two, I can't remember now. It has been a long
time.
Use Oncology library. Our medications that have multiple drugs in them are
not listed; such as Ondansetron and Dexamethasone or Etoposide,
Doxorubicin & Vincristine.
cant remember
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Nursing Areas by Written Responses to Question 8
Peds- both cc/floor
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Meduflex -both P/A
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All Medical/Surgical Floors

44%
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Figure 4.14 Percent of Written Responses to Post-Survey Question 8
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Table 4.10 Written Responses to Post-Survey Question 8
Nursing Unit
Category

C

I

M

58
MS

Comments: Survey Question: 8
certain anti-rejection meds
n/a
NA
neosynepherine
Potassium 20mg/100mL
Several antibiotics - I always report this to my pharmacist
avolumab
don't remember at this time
For everything I hang I look in the guardrails, if I dont see it I look a second time then
hang the med as basic. I can't think of any off the top of my head.
I do not remember. rarely have this issue.
n/a
numerous cant remember
albumin
As listed above.
can't remember the actual drug name
Can't remember; it's been awhile since this has happened.
chemo drugs not present in Adult guardrail library
D5 1/2NS + additive
Desmopressin
I am able to find most of the drugs I need
idk
mix drugs ( zofran and decadron) for example
Phenergan occasionaly on certain brains
Same as above

Nursing Areas by Written Responses to Question 9
Peds- both cc/floor

0%

Specialty Areas

2%

Infusion Cancer Center

7%

Meduflex -both P/A

16%

Critical Care

33%
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All Medical/Surgical Floors
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Figure 4.15 Percent of Written Responses to Post-Survey Question 9
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Center areas, 2% (n=1) from Specialty nursing areas, and 0 responses from Pediatric
areas. All written responses to survey question 9 were extracted in whole and presented
in Table 4.11. The codes for each nursing unit category presented in table 4.11 are
displayed in Table 4.2.

The final question from the 2017 post-intervention query reports data related to
the facility’s current 2017 AGAC process, and accounts on staff nurses participation with
the smart pump champions on their nursing units. Question 10 in the post-survey asked,
“Have you had the opportunity to work with the Alaris Guardrails™ Audit Champions on
your unit or any other nursing units?” There were 148 responses, with 76% (n=113)
reporting they had not work with the Alaris Guardrails™ Audit Champions, and 24%
(n=35) reporting that they had worked with the Alaris Guardrails™ Audit Champions
(Figure 4.16).

Analysis of Pre and Post-Survey

Several frequencies and t-tests were performed in SAS (version 9.4) to assess for
differences among the pre and post-survey, and differences amongst each demographic
variable (e.g. level of education, years of nursing experience, and age) compared to
barrier choices listed in question 3 of the pre-survey and question 6 of the post-survey
(e.g., barrier 1: I have looked/asked and the drug I need isn’t in the Guardrails™ library,
barrier 2: I am having trouble finding the drugs I need in the different Guardrails™
libraries, barrier 3: I don’t have enough time to use Guardrails™/using Guardrails™ is
tedious, barrier 4: I didn’t receive training or education on using Guardrails™, barrier 5:
Existing Guardrails™ settings don’t match with workflows in my area, barrier 6: other).
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Table 4.11 Written Reponses to Post-Survey Question 9
Nursing
Unit
Category

C

I

M

MS

Comments Survey Question: 9
correct concentration of drugs not in pump
Habit
I am unaware this is protocol or at least don't recall receiving education about it being
required. Does it have to be for meds other than IVF or for everything on a pump? Is it
required? ALSO, it is the responsibility of the RN to update the patient's weight daily so
they receive the right amount of drugs - I FREQUENTLY see this not being done. This is
especially important for BP, cardiac, and sedation meds and should be addressed ASAP.
I have not experienced any barriers
I have only found one drug not in library. I always us
i use it most of the time.
I use the guardrails with drips, but for MIVF, find it more of a hassle to search for fluid
rather than just use basic infusion
Most of the time I find the drugs I need
N/A
No barriers
No barriers.
Only running antibiotic and it's not available as primary option
some drugs don't have same concentrations or calculations used in unit
h
I use guardrails if the drug isn't listed, I send a message to have it updated
I don't have trouble using the guardrails, I use them consistently as long as the medication I
need is listed
I have no barriers, guardrails are used
I use guardrails if the drug isn't listed, I send a message to have it updated
I don't have trouble using the guardrails, I use them consistently as long as the medication I
need is listed
I have no barriers, guardrails are used
air in line
I always use the library
I don't have any barriers to Guardrails, I don't use IV pumps often or in pressure situations
I don't have barriers to guardrails currently, all drugs I have mentioned have been added
I have not met any barriers yet.
N/A
No barriers
all of the drugs we give are in the Alaris pump
I always use guardrails, occassionally may change rate depending on access but have not
had any issues
I do not have any issue or barriers with the guardrails
I do not work with the Alaris pumps often, and do not find many barriers to their use.
I don't have any barriers. I always use guardrails.
I don't really have trouble using it.
I have been able to use the Guardrails library without difficulty
i have no barriers
I have no issues using the guardrail library
I have no issues with Guardrails
I typically use the guardrails features
I've had very rarely used 'basic infusion' on med/surg units.
N/A
None of the above, I have received proper training and use the guardrails appropriately.
none, I use them all the time
patient specific needs ie-chf & vanco @ 250 ml/hr 750ml bag
Tedious
s
I have yet to use a pump as a new grad
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Opportunity to Work with
the Alaris Guardrails Audit
Champions?
Yes
24%
No
76%

Yes

No

Figure 4.16 Work with Alaris Guardrails™ Audit Champions

The frequencies of variables compared in the pre and post survey is presented in
Table 4.12. The information in Table 4.12 shows the frequency distribution of barriers by
pre and post-intervention. The p-value for the chi square test was .0038 for barrier one,
.0526 for barrier two, .1276 for barrier three, .1830 for barrier four, .0033 for barrier five,
and .0375 for barrier six as presented in Table 4.12. The results showed about 35.48%
(n=55) of post intervention looked/asked and the drug was not in Guardrails™ library as
compare to pre intervention about 52.94% (n=63) (p value=.0038), 11.61% (n=18) of
post-intervention existing Guardrails™ settings don’t match with workflows as compared
to pre-intervention about 25.21% (n=30) (p value=.0033), and 26.45% (n=41) of postintervention identified that there were other barriers to the use of Guardrails™ as
compared to pre-intervention about 15.97% (n=19) (p-value =.0375). All other barriers
reported a p-value >.05 showed no significances.
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Table 4.12 Frequency Distribution of Barriers by Pre and Post-Interventions
Variables*

Pre-Survey (N=119)
N

1. I have looked/asked and the drug
I need isn’t in the Guardrails
library.
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No
Yes
2. Iam having trouble finding the
drugs I need in the different
Guardrails libraries.
No
Yes
3. I don’t have enough time to use
Guardrails/using Guardrails is
tedious.
No
Yes
4. I didn’t receive training or
education on using Guardrails.
No
Yes
5. Guardrails settings don’t match
with workflows in my area.
No
Yes
6. Other
No
Yes

Post Survey (N= 155)

p-value

%

N

%

56
63

47.06
52.94

100
55

64.52
35.48

.0038

97
22

81.51
18.49

139
16

89.68
10.32

.0526

111
8

93.28
6.72

136
19

87.74
12.26

.1276

110
9

92.44
7.56

149
6

96.13
3.87

.1830

89
30

74.79
25.21

137
18

88.39
11.61

.0033

100
19

84.03
15.97

114
41

73.55
26.45

.0375

The frequency distribution of barriers by level of nursing education is displayed in
Table 4.13. The p-value for the chi square test was .8282 for barrier one, .3244 for barrier
two, .1759 for barrier three, .4008 for barrier four, .6025 for barrier five, and .1744 for
barrier six as displayed in Table 4.13. The chi square test for all p-value results were
>.05, which indicated there were no significant differences among the level of nursing
education on barriers.

The frequency distribution of barriers by years of nursing experience is displayed
in Table 4.14. The p-value for the chi square test was .0876, for barrier one, .1611 for
barrier two, .1097 for barrier three, .5157 for barrier four, .1875 for barrier five, and
.1744 for barrier six as presented in Table 4.14. The results revealed no significant
differences exist between years of nursing experience and barriers to Guardrails™ usage.

The frequency distribution of barriers by age is displayed in Table 4.15. The pvalue for the chi square test was .0581 for barrier one, .0432 for barrier two, .3989 for
barrier three, .9592 for barrier four, .0847 for barrier five, and .2242 for barrier six as
displayed in table 4.15. The results showed a p-value < .05 for barrier two (pvalue=.0432), suggesting there is enough evidence to support that differences exist
between the age of nurses and trouble with finding the drugs in different Guardrails™
libraries. The post-intervention barriers by age showed about 18.18% (n=12) of
participants 29-39yrs, and 9.52% (n=4) of the participants 18-28yrs, post-intervention
had trouble finding the drugs in the different Guardrails libraries (p-value=.0432). All
other p-values provided no significance since all other values were >.05.
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Table 4.13 Frequency Distribution of Barriers by Level of Nursing Education
Post-Survey (N=153)
Variables*
1. I have looked/asked and
the drug I need isn’t in the
Guardrails library.
No
Yes
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2. Iam having trouble
finding the drugs I need in
the different Guardrails
libraries.
No
Yes
3. I don’t have enough time
to use Guardrails/using
Guardrails is tedious.
No
Yes
4. I didn’t receive training
or education on using
Guardrails.
No
Yes
5. Guardrails settings
don’t match with
workflows in my area.
No
Yes
6. Other
No
Yes

Associates
N

%

Bachelors
N

%

Graduate
N

18
12

60
40

71
39

64.55
35.45

9
4

69.23
30.77

.8282

28
2

93.33
20.29

97
13

88.18
11.82

13
0

100
0

.3244

29
1

96.67
3.33

93
17

84.55
15.45

12
1

92.31
7.69

.1759

30
0

100
0

105
5

95.45
4.55

12
1

92.31
7.69

.4008

28
2

93.33
6.67

96
14

87.27
12.73

11
2

84.62
15.38

.6025

23
7

76.67
23.33

81
29

73.64
26.36

8
5

61.54
38.46

.5782

p-value
%

Table 4.14 Frequency Distribution of Barriers by Years of Nursing Experience
Post-Survey (N=154)
Variables*
1. I have looked/asked and the
drug I need isn’t in the
Guardrails library.
No
Yes
2. Iam having trouble finding
the drugs I need in the different
Guardrails libraries.
No
Yes
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3. I don’t have enough time to
use Guardrails/using
Guardrails is tedious.
No
Yes
4. I didn’t receive training or
education on using Guardrails.
No
Yes
5. Guardrails settings don’t
match with workflows in my
area.
No
Yes
6. Other
No
Yes

0-5yrs.
N

%

6-11yrs.
N

49
37

56.98
43.02

27
8

77.14
22.86

13
3

81.25
18.75

11
6

64.71
35.29

.0876

73
13

84.88
15.12

33
2

94.29
5.71

15
1

93.75
6.25

17
0

100
0

.1611

77
9

89.53
10.47

33
2

94.29
5.71

12
4

75
25

13
4

76.47
23.53

.1097

81
5

94.19
5.81

34
1

97.14
2.86

16
0

100
0

17
0

100
0

.5157

72
14

83.72
16.28

32
3

91.43
8.57

15
1

93.75
6.25

17
0

100
0

.1875

68
18

79.07
20.93

23
12

65.71
34.29

9
7

56.25
43.75

13
4

76.47
23.53

.1744

%

12-17yrs.
N

%

18+yrs
N

p-value
%

p-value

61+yrs.

51-61yrs.

40-50yrs.

Variables*

29-39yrs.

Post-Survey (N=155)

18-28yrs.

Table 4.15 Frequency Distribution of Barriers by Age
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Barriers
1. I have looked/asked, and
the drug I need isn’t in the
Guardrails library.

N

%

N

%

N

%

N

%

No
Yes

23
19

54.76
45.24

48
18

72.73
27.27

15
15

50
50

12
3

80
20

2
0

100
0

.0581

38
4

90.48
9.52

54
12

81.82
18.18

30
0

100
0

15
0

100
0

2
0

100
0

.0432

37
5

88.10
11.90

58
8

87.88
12.12

28
2

93.33
6.67

11
4

73.33
26.67

2
0

100
0

.3989

40
2

95.24
4.76

64
2

96.97
3.03

29
1

96.67
3.33

14
1

93.33
6.67

2
0

100
0

.9592

33
9

78.57
21.43

58
8

87.88
12.12

29
1

96.67
3.33

15
0

100
0

2
0

100
0

.0847

32
10

76.19
23.81

47
19

71.21
28.79

25
5

83.33
16.67

8
7

53.33
46.67

2
0

100
0

.2242

2. I am having trouble
finding the drugs I need in
the different Guardrails
libraries.
No
Yes
3. I don’t have enough time
to use Guardrails/using
Guardrails is tedious.
No
Yes
4. I didn’t receive training
or education on using
Guardrails.
No
Yes
5. Guardrails settings don’t
match with workflows in
my area.
No
Yes
6. Other
No
Yes

N

%

Summary

The information presented in Chapter IV was analyzed to identify factors that
influenced the use of Guardrails™ by nurses. The findings indicated that all but one
demographic variable (e.g. age) were related to identified barriers. All nurses
regardless of education, time in the workforce, and age identified similar barriers to
use of Guardrails™ on smart pumps. There was a correlation between IV medication
errors and use of Guardrails™. The higher the percentage of use of Guardrails™ the
lower IV medication errors. Although the facility did not meet the benchmark, data
indicated that the interventions did increase the use of Guardrails™ from 63% to
88%. It will be vital for the AGT to establish a plan for continuous quality
improvement with the goal of meeting the benchmark set at 90 to 100% of the time.
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CHAPTER V
DISCUSSION

The purpose of this quality improvement project was to conduct a systematic
organizational assessment to identify the factors that influence the use of Guardrails™ by
nurses, implement interventions based on the assessment, measure outcomes, and make
recommendations for future change in order to foster continued progress toward the
facility’s goal set at 90-100% Guardrails™ use. The project used a descriptive approach
to conduct an organizational assessment. The project included all nursing units with staff
nurses who utilized Guardrails™ on IV smart pumps in their daily workflows. All
statistical information collected for this project was analyzed using SAS statistical
software (version 9.4) and Excel® software. The SAS (version 9.4) analysis software was
used to analyze frequencies, using the t-test to compare results from the 2015 pre-survey
and the 2017 post-survey. Frequencies, the t-test, and z-scores were also used to analyze
and compare Guardrails™ compliance data and self-reported IV medication errors.
Excel® was used to categorize data from the “primary working unit” variable to identify
themes and formulate codes for each area of nursing; doing so allowed a visual
presentation of the frequency of responses from each nursing area. Tables and graphs
were also created in Excel® to display the results.
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Implications of Findings

The data results from the Guardrails™ compliance report and self-reported IV
medication errors between 2015 and 2017 provided enough evidence to suggest that a
structured continuous education plan is essential to increase nurses’ awareness and
adherence to policies and procedures governing the use of Guardrails™ on IV smart
pumps. The data collected in this project was assessed and the information obtained
offered reasonable answers to each of the four prospective questions mentioned in
Chapter I.

Question One

The question of whether a relationship existed between Guardrails™ compliance
and self-reported IV medication errors were probed by asking, “As IV smart pump’s
Guardrails™ compliance rate increases, does the rate of IV medication errors decrease?”
Data revealed that as the IV smart pumps Guardrails™ compliance rate increases, the rate
of IV medication errors decreases, having z-test results with a p-value less than .00001.
The p-value was significant and suggested that the proportion of nurses using
Guardrails™ was high post interventions (.81), compared to pre-intervention (.71), which
also implies that as Guardrails™ compliance increased, self-reported IV medication
errors decreased. The literature has emphasized that a structured continuous education
program is beneficial when smart pumps are first implemented in hospitals. The evidence
strongly suggests that in order to foster increased compliance scores, collaboration with
hospital stakeholders, pharmacy, nurses, unit managers, and information technology,
forming unit champions, and establishing a continuing education program are all essential
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elements that directly impact Guardrails™ compliance and improved patient safety
outcomes.

Question Two

The second question postulated in Chapter I asked, “Does the number of IV
medication errors decrease with the implementation of each intervention? If so, what
factors significantly impact increasing compliance rates and why?” The institution
incorporated several change processes to increase their nurses’ awareness, adherence, and
compliance to Guardrails™ on smart pumps. The facility updated their drug libraries
each quarter to allow sufficient time for new drugs to be added to their smart pumps,
added education on the use of Guardrails™ for new hires and new nurses’ orientation,
consolidated their drug libraries for a universal approach to Guardrails™ use and
features, offered educational workshops, quick reference guides, re-organized their drug
libraries, and implemented an audit champion initiative in order to assist with increasing
staff nurses’ knowledge, awareness, and adherence to the safety feature on smart pumps.
Beginning in 2015, interventions implemented throughout the course of this project and
positively contributed to an increase in Guardrails™ compliance, which decreased the
rate/risk of IV medication errors. The data reported that a correlation exists between
Guardrails™ usage and IV medication errors.

Recognizing the correlation between Guardrails™ usage and self-reported IV
medication errors answers the question of whether the number of IV medication errors
decreases as Guardrails™ compliance increases, but how it was impacted by
implementation of each intervention cannot be determined. However, the factor of
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“awareness” contributed to a decrease in IV medication errors, since all interventions
directly impacted nurses’ awareness to utilize Guardrails™ on smart pumps. Hence,
increasing Guardrails™ usage is regarded as an effective preventive measure to decrease
IV medication errors. As a result, monitoring monthly Guardrails™ compliance data as
yearly reports, compared to the yearly accounts of self-reported IV medication errors,
offered the institution a means to assess their progress towards the 90-100% benchmark,
assess their current policies and procedures on the use of Guardrails™ on smart pumps,
and offered them guidance with decision making on any future interventions that needed
to be made moving forward.

Question Three

The third inquiry from Chapter I addressed data on new barriers to the use of
Guardrails™ that were reported from the post-survey. The question asked, “Are there any
new barriers identified by staff nurses, and if so, what are these barriers?” The 2017 postsurvey offered an array of data to assess and determine if new barriers on the use of
Guardrails™ existed post-implementation of all the various interventions from 20152017. For example, 26.45% (n=41) of the nurses assessed post-intervention identified
that there were other barriers to the use of Guardrails™, as compared to 15.97% (n=19)
of them pre-intervention (p-value =.0375), which suggested other barriers were
identified. All data captured as written comments in the post-survey suggested that there
were new barriers. For example, three participants, all from the Critical Care areas,
reported each statement presented below.
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“I am unaware this is a protocol or at least don't recall receiving education about
it being required. Does it have to be for meds other than IVF or for everything on a
pump? Is it required?”

“I have only found one drug not in library. I always use it most of the time.”

“I use the guardrails with drips, but for MIVF, find it more of a hassle to search
for fluid rather than just use basic infusion.”

All the comments presented above suggest that the new barriers include unclear
policies and procedures governing the use of Guardrails™, drugs being missing from the
libraries, and interference with workflows. The information revealed that it is worthwhile
to update policies governing IV medication administration, for the pharmacy to quickly
update new medications as they become readily available for use on smart pumps, and
reinforce saying “no to basic infusion” while emphasizing the importance of correctly
using the IV technology for the effective and compliant use of Guardrails™ in all nursing
areas. In addition, all significant p-values in the post-surveys’ chi-square test was .0038,
which suggests that about 35.48% (n=55) of the nurses, post-intervention, looked/asked
and the drug was not in the Guardrails™ library, compared to 52.94% (n=63) of nurses
pre-intervention (p-value=.0038). Approximately 11.61% (n=18) of the post-intervention
agreed that Guardrails™ settings did not match with their workflows, as compared to
25.21% (n=30) pre-intervention (p-value=.0033), and 26.45% (n=41) of the nurses
assessed post-intervention identified that there were other barriers to the use of
Guardrails™, as compared to 15.97% (n=19) of them pre-intervention (p-value =.0375).
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Question Four

The last question from Chapter I asked, “Does the post-nursing survey report an
increase in staff nurses’ knowledge and awareness regarding the proper utilization and
adherence to the IV smart pump’s Guardrails™ policies and procedures?” The data
reported in this project suggest that incongruences may exist with nurses’ awareness of
the proper utilization and current procedures on the use of Guardrails™ (see reports from
Question Three). Also, the results presented in Figure 4.16 report that regarding
awareness of the current procedure surrounding implementing an Alaris Guardrails™
Audit Champion on all nursing units hospital-wide, 76% (n=113) of the 148 respondents
reported that they had not had the opportunity to work with the audit champions and 24%
(n=35) reported that they had worked with the audit champions. The information
gathered suggest that nurses are aware of this new procedure governing the use of
Guardrails™.

Limitations

There were several limitations identified in the project. First, the application of
using a survey tool presented biases, such as the risk of participants providing untruthful
answers, the risk of data error occurrences with some respondents who did not respond,
and the risk of participants misinterpreting the “yes” and “no” questions. Second, similar
demographic data should have been used in both surveys to offer broader insights on
variations that may have existed among the variable “age” and all barriers pre- and postinterventions since the frequency distribution of post-intervention barriers by age showed
about 18.18% (n=12) of participants 29-39yrs, and 9.52% (n=4) of the participants 18-
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28yrs, post-intervention had trouble finding the drugs in the different Guardrails libraries
(p-value=.0432). Third, it could not be determined if the same participants who
participated in the pre-survey also participated in the post-survey; having the same
participants in both surveys could have increased the reliability of the results. Also, there
was a low response rate for both the pre-survey (N=119) and post-survey (N=155). Even
so, the post-intervention survey had a higher response rate, which was partially due to
having the hospital’s ACNO present the post-survey to unit managers and their nursing
staff as compared to the pre-survey, which was presented by members of the AGT.

As a result, incorporating a more creative plan to engage staff to participate in
surveys is warranted since higher response rates offer fewer non-response biases.
However, using the same survey for both the pre- and post-interventions was beneficial
for identifying any new barriers to the use of Guardrails™, identifying a need to make
any new changes to current interventions intended to increase nurse use of Guardrails™
on smart pumps, and offering significant information on the overall progress of the
current interventions.

Implications for Nursing

Guardrails™ were added to the smart pumps in 2010 to assist with lowering the
risk of IV medication errors. There were several self-reported cases of IV medication
errors within the facility even after Guardrails™ were added. The institution failed to
establish an effective education and compliance monitoring plan when the smart pumps
were integrated, and nurses failed to use the safety features on smart pumps. Both nursing
leaders and nursing staff need to understand the purpose of the safety features on smart
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pumps as well as the policies and procedures governing their use. Nurses need to be
aware that compliance with Guardrails™ supports adhering to the five rights of IV
medication administration; in this case, the “right dose/rate” will be established when
Guardrails™ are in use.

When continuous educational initiatives are implemented in facilities, continual
support from hospital leaders is essential, because staff tend to participate more readily
when stakeholders are included in initiatives. Patient safety is always the first priority, so
nurses need to understand the true value of using Guardrails™ on smart pumps despite
fostering a culture of workarounds. Nursing leaders need to emphasize that it is
imperative that staff nurses understand how to correctly operate the IV smart pump
technology and utilize its safety features because it decreases the risk of IV medication
errors and improves patient safety and outcomes when used properly. In order to ensure
that Guardrails™ compliance data are captured from each nursing unit when nursing staff
are required to enter a specified unit ID number into the smart pumps for appropriate data
retrieval, nursing leaders need to establish an effective method to share each unit’s ID
number with all nursing staff, specifically Meduflex float pool nurses, in the event that
they would need to float to other units. Ongoing education on the use of Guardrails™ on
smart pumps is necessary for hospital facilities.

More importantly, all information summarized in this quality improvement
project provides nursing stakeholders with the opportunity to address their reported
compliance rates by emphasizing legal liabilities if there’s an issue of noncompliance
with the use of Guardrails™ on smart pumps (ISMP, 2009).
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Recommendations

Smart pumps are smart when nursing end-users are properly trained on utilizing
the technology to administer IV medications. Also, nursing end-users need to make the
right decision to use the appropriate library within the smart pump’s safety features.
Failure to comply with the safety features increases the risk of IV medication errors,
which runs the risk of harming or even killing a patient. However, when policies are not
accurately set in place to govern certain procedures within facilities, and failing to
establish an effective education and compliance monitoring plan upon integrating smart
pumps, the staff will lack support and education regarding making the right decisions. As
a result, questions arise regarding the procedure and patients are put at risk.

Therefore, nursing leaders need to collaborate with hospital stakeholders and their
quality departments to re-assess policies governing IV medication administration. IV
medication administration policies need to reflect evidence-based data on the use of smart
pumps with Guardrails™. Nursing leaders need to also ensure that Guardrails™ drug
libraries are continuously updated as formulary changes are made, and establish an
effective plan of sharing each units’ ID number with all staff nurses, especially Meduflex
(float pool nurses) in the event that they would need to float to other units.

Establishing an effective on-going education plan and monitoring monthly
Guardrails™ compliance data compared to self-reported IV medication error occurrences
are important matters to consider when smart pumps are used in hospitals. A systematic
organizational assessment was conducted to identify barriers to nurses’ use of
Guardrails™ on smart pumps. The project demonstrated that when barriers to the use of
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Guardrails™ are identified, addressing those issues are just as important as nurses
complying with the safety features of smart pumps. When issues pertaining to drug
libraries are presented by nursing end-users and if they are not addressed, the issue of
noncompliance to Guardrails™ will continue, self-reported IV medication errors will
increase, and the risk of harming a patient will also increase. This project demonstrated
that implementing various structured education processes and informational initiatives
that aim to increase nurse’s knowledge, awareness, and adherence to Guardrails™ on
smart pumps has a positive impact on increasing compliance scores, decreasing IV
medication errors, and improving patient safety.

The collection of various comments from the survey participants suggest that
nurses have a great deal to say regarding Guardrails™ usage at the facility. Therefore,
nursing leaders should conduct informal interviews with nursing end-users, as doing so,
may offer further insights on barriers to the use of Guardrails™.

Conclusions

Adherence to Guardrails™ on smart pumps, ensuring that the drug libraries are
updated frequently, and sharing each units ID number with all staff nurses, especially
Meduflex (float pool nurses) in the event they would need to float to other units is
warranted. Doing so, increases Guardrails™ compliance scores, decreases IV medication
errors, and improves patient safety. However, nurses still fail to utilize the safety features.
The evidence collected in this project provides data that support establishing an organized
education program that aims to identify barriers to nurses’ use of Guardrails™ and
increase nurses’ use of Guardrails™ in order to increase compliance scores over time. In
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2010, the facility identified that nurses were utilizing Guardrails™ safety features <75%
of the time. The facility then took the initiative to identify why the issue of
noncompliance was occurring, implemented various interventions based on their
findings, measured outcomes from their interventions, and finally adopted a continuous
educational audit process that supported the hospital's culture. All interventions had a
positive impact on increasing the institutions’ averaged yearly compliance scores from
75% to 88%, and 90% as of September 2017.
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